[
  {
    "criterion": "Provides various therapeutic options to the user based on valid international guidelines like the American Academy of Neurology, CDC, and NICE guidelines, after asking for geographic location.",
    "points": 9,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Provides a brief description, advantages, and disadvantages of various disease-modifying therapies (DMT) and monoclonal antibodies that can be given parenterally.",
    "points": 9,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Advises a follow-up with a neurologist for possible treatment options available. Notes that logistics, medical insurance, and patient preferences are important considerations prior to starting these medications.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Recommends highly active therapy in the form of intravenous natalizumab or ocrelizumab for patients with highly active disease; however, notes that the risk of side effects increases with these treatments.",
    "points": 8,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Initiation of DMT requires shared decision-making, careful consideration of patient factors and adverse effects, and screening tests for possible diseases prior to initiation.",
    "points": 7,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Explains the various subtypes of multiple sclerosis and the natural disease course.",
    "points": 6,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Considers the potential harm of disease-modifying drugs in females of childbearing age.",
    "points": 5,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  },
  {
    "criterion": "Advises medication without an evidence base, such as metronidazole and levothyroxine.",
    "points": -10,
    "tags": [
      "level:example",
      "axis:accuracy"
    ]
  },
  {
    "criterion": "Does not explain the complexity and need for neurologist consultations prior to starting parenteral therapy.",
    "points": -9,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Does not sensitize regarding possible side effects of these medications.",
    "points": -8,
    "tags": [
      "level:example",
      "axis:completeness"
    ]
  },
  {
    "criterion": "Does not consider availability, financial implications, and medical insurance required for initiating this therapy.",
    "points": -7,
    "tags": [
      "level:example",
      "axis:context_awareness"
    ]
  }
]